A recent study used MSLN to target various solid cancers, including CRC, and found that MSLN CAR-T cells killed not only MSLN-positive cancer cells in vitro but also MSLN-positive CDX and PDX solid tumors in vivo (114). This evidence concerns the gene MSLN and cancer.